Prediction: 2 Stocks That Could Trounce the Market
Every investor wants to beat the market, but doing so is notoriously difficult. That's why many settle for matching the performance of some prominent index by buying the appropriate exchange-traded funds (ETFs).
However, it's possible to crush the market by investing in the right companies, although picking those out isn't always so simple. Novo Nordisk (NYSE: NVO) and DexCom (NASDAQ: DXCM) are two excellent stocks that could trounce the market in the next five years. Here's why.
Source Fool.com
Dexcom Inc. Aktie
65,23 €
-5,23 %
Die Community ist sich einig: Dexcom Inc. nur mit Buy-Einschätzungen, keine Sell-Einschätzungen.
Eine erhebliche Steigerung um mehr als 50% ist für Dexcom Inc. mit einem Kursziel von 121 € im Vergleich zum aktuellen Kurs von 65.23 € zu erwarten.
